Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
HR+/HER2- Breast Cancer
Hangzhou, Zhejiang
HR+/HER2- Breast Cancer Clinical Trials in Hangzhou, Zhejiang
1 recruiting
Hangzhou, Zhejiang, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)
HR+/HER2- Breast Cancer
First Affiliated Hospital of Zhejiang University
35 enrolled
3 locations
NCT06874933
Feedback